United States · FDA National Drug Code directory
Kerendia
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-542_28aa9af2-2939-46e0-8c9c-af939e81b551
- Product NDC
- 50419-542
- Form
- TABLET
- Composition / generic term
- finerenone
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210709
- Source listing expiry
- 20261231
Source-listed ingredients
- FINERENONE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE, PLASTIC (50419-542-01) · 50419-542-01
- 90 TABLET in 1 BOTTLE, PLASTIC (50419-542-02) · 50419-542-02
- 10 TABLET in 1 BLISTER PACK (50419-542-06) · 50419-542-06
- 7 TABLET in 1 BOTTLE, PLASTIC (50419-542-70) · 50419-542-70
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →